To investigate the association of the level of spike-specific IgA in the nasal passage with the risk of reinfection, the ICT strip was used to evaluate nasal swab samples from 140 donors who experienced an Omicron BA.5 infection after the lift of zero-COVID policy during December 2022 to January 2023. The gene discussed is CD79A; the disease is infection.